Scholarly Index
YL Lau
University of Hong Kong; 34,218 total citations; 997 total publications; best world rank #106
University of Hong Kong
34,218Total citations
997Total publications
90H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 130 | CN 25 | 99.25 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 151 | CN 26 | 99.31 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 166 | CN 1 | 99.07 |
| Influenza Virus Research Studies | Lifetime | 376 | CN 32 | 98.25 |
| Respiratory viral infections research | Lifetime | 511 | CN 32 | 98.18 |
| Systemic Lupus Erythematosus Research | Lifetime | 958 | CN 26 | 97.36 |
| Pneumonia and Respiratory Infections | Lifetime | 994 | CN 10 | 96.99 |
| Blood disorders and treatments | Lifetime | 364 | CN 2 | 95.91 |
| Complement system in diseases | Lifetime | 568 | CN 8 | 95.47 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 987 | CN 14 | 95.64 |
| Immune responses and vaccinations | Lifetime | 221 | CN 6 | 93.30 |
| Bacterial Infections and Vaccines | Lifetime | 968 | CN 9 | 94.02 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 106 | CN 2 | 96.85 |
| Viral Infections and Immunology Research | 2021-2025 | 756 | CN 197 | 84.32 |
| Blood disorders and treatments | 2021-2025 | 237 | CN 5 | 82.44 |
| Kawasaki Disease and Coronary Complications | 2021-2025 | 965 | CN 108 | 66.63 |